a public good project by the
Synthesis
Company
of California

© 2026

Andrea Rinaldi | doi.page

0 works0 citations0 h-index

Andrea Rinaldi

Institute of Oncology Research(CH)

Publications by Year

Research Areas

Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Cutaneous lymphoproliferative disorders research, Protein Degradation and Inhibitors, PI3K/AKT/mTOR signaling in cancer

Most-Cited Works

→ Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1–polarizing program in dendritic cells(2005)1,145 cited
→ Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma(2015)435 cited
→ The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development(2012)378 cited
→ IL-23 secreted by myeloid cells drives castration-resistant prostate cancer(2018)377 cited
→ Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis(2021)307 cited
→ The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted Drugs(2015)282 cited

→ Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome(2013)

249 cited

→ The NF-κB negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas(2009)242 cited

→ Re-education of Tumor-Associated Macrophages by CXCR2 Blockade Drives Senescence and Tumor Inhibition in Advanced Prostate Cancer(2019)227 cited

→ Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer(2018)193 cited